Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism

PHASE2CompletedINTERVENTIONAL
Enrollment

271

Participants

Timeline

Start Date

May 12, 2016

Primary Completion Date

February 15, 2018

Study Completion Date

May 19, 2018

Conditions
Hypogonadotropic Hypogonadism
Interventions
DRUG

BGS649

Capsules were taken weekly for a maximum of 24 weeks

DRUG

Placebo

Capsules were taken weekly for a maximum of 24 weeks

Trial Locations (63)

Unknown

Mereo Research Site, Birmingham

Mereo Research Site, Mobile

Mereo Research Site, Chandler

Mereo Research Site, Phoenix

Mereo Research Site, Scottsdale

Mereo Research Site, Anaheim

Mereo Research Site, Carlsbad

Mereo Research Site, Greenbrae

Mereo Research Site, Lincoln

Mereo Research Site, Los Angeles

Mereo Research Site, San Diego

Mereo Research Site, Bradenton

Mereo Research Site, DeLand

Mereo Research Site, Fort Myers

Mereo Research Site, Hialeah

Mereo Research Site, Homestead

Mereo Research Site, St. Petersburg

Mereo Research Site, Meridian

Mereo Research Site, Gurnee

Mereo Research Site, Evansville

Mereo Research Site, New Orleans

Mereo Research Site, Baltimore

Mereo Research Site, Elkridge

Mereo Research Site, St Louis

Mereo Research Site, Omaha

Mereo Research Site, Henderson

Mereo Research Site, Las Vegas

Mereo Research Site, Albany

Mereo Research Site, Garden City

Mereo Research Site, Great Neck

Mereo Research Site, New York

Mereo Research Site, Rochester

Mereo Research Site, Charlotte

Mereo Research Site, Raleigh

Mereo Research Site, Winston-Salem

Mereo Research Site, Middleburg Heights

Mereo Research Site, Mt. Pleasant

Mereo Research Site, Nashville

Mereo Research Site, Smyrna

Mereo Research Site, Spring Hill

Mereo Research Site, Dallas

Mereo Research Site, Fort Worth

Mereo Research Site, Pearland

Mereo Research Site, San Antonio

Mereo Research Site, Murray

Mereo Research Site, West Jordan

Mereo Research Site, Norfolk

Mereo Research Site, Kenosha

Mereo Research Site, Ancona

Mereo Research Site, Parma

Mereo Research Site, Roma

Mereo Research Site, Siena

Mereo Research Site, Coslada

Mereo Research Site, Girona

Mereo Research Site, Madrid

Mereo Research Site, Majadahonda

Mereo Research Site, Barnsley

Mereo Research Site, Coventry

Mereo Research Site, Dundee

Mereo Research Site, Edinburgh

Mereo Research Site, Hull

Mereo Research Site, Manchester

Mereo Research Site, Newcastle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mereo BioPharma

INDUSTRY

NCT02730169 - Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism | Biotech Hunter | Biotech Hunter